Bergot E - Search Results

1

Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.

Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Guignabert C, et al. Among authors: bergot e. Circulation. 2023 Jun 13;147(24):1809-1822. doi: 10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. Circulation. 2023. PMID: 37096577

2

In vivo probe-based confocal laser endomicroscopy in chronic interstitial lung diseases: Specific descriptors and correlation with chest CT.

Salaün M, Guisier F, Dominique S, Genevois A, Jounieaux V, Bergot E, Thill C, Piton N, Thiberville L. Salaün M, et al. Among authors: bergot e. Respirology. 2019 Aug;24(8):783-791. doi: 10.1111/resp.13507. Epub 2019 Feb 27. Respirology. 2019. PMID: 30811085

3

[Malignant pleural mesothelioma: 2013 state of the art].

Campbell K, Brosseau S, Reviron-Rabec L, Bergot E, Lechapt E, Levallet G, Zalcman G. Campbell K, et al. Among authors: bergot e. Bull Cancer. 2013 Dec;100(12):1283-93. doi: 10.1684/bdc.2013.1857. Bull Cancer. 2013. PMID: 24225007 Review. French.

4

Sarcoidosis.

Bergot E, Paparel P, Zalcman G. Bergot E, et al. N Engl J Med. 2008 Mar 27;358(13):1404; author reply 1404-5. N Engl J Med. 2008. PMID: 18376441 No abstract available.

5

[Stage IV NSCLC. Biological treatments of lung cancer in 2008... and in the near future].

Bergot E, Levallet G, Zalcman G. Bergot E, et al. Rev Mal Respir. 2008 Oct;25(8 Pt 2):3S119-26. Rev Mal Respir. 2008. PMID: 18971836 French.

6

[Interest of collapse therapy in pulmonary extensively drug-resistant tuberculosis].

Haustraete E, Campbell K, Magnier R, Zalcman G, Bergot É. Haustraete E, et al. Among authors: bergot e. Rev Pneumol Clin. 2014 Aug;70(4):240-4. doi: 10.1016/j.pneumo.2013.08.007. Epub 2013 Nov 5. Rev Pneumol Clin. 2014. PMID: 24210158 French.

7

[Genetic susceptibility for lung cancer and nicotinic addiction: toward a molecular explanation?].

Bergot E, Levallet G, Zalcman G. Bergot E, et al. Rev Mal Respir. 2008 May;25(5):519-22. doi: 10.1016/s0761-8425(08)71607-3. Rev Mal Respir. 2008. PMID: 18535517 French. No abstract available.

8

An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.

de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, Richard N, Antoine M, Rouquette I, Favrot MC, Debieuvre D, Braun D, Westeel V, Quoix E, Brambilla E, Hainaut P, Moro-Sibilot D, Morin F, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique. de Fraipont F, et al. Among authors: bergot e. Clin Cancer Res. 2012 May 15;18(10):2976-86. doi: 10.1158/1078-0432.CCR-11-2797. Epub 2012 Mar 20. Clin Cancer Res. 2012. PMID: 22434665 Clinical Trial.

9

Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?

Zalcman G, Bergot E, Lechapt E. Zalcman G, et al. Among authors: bergot e. Lung Cancer. 2011 Apr;72(1):1-2. doi: 10.1016/j.lungcan.2010.12.021. Epub 2011 Jan 28. Lung Cancer. 2011. PMID: 21277041 No abstract available.

10

Modalities of ventilation in patients with human immunodeficiency virus infection.

Gachot B, Bergot E, Bédos JP. Gachot B, et al. Among authors: bergot e. Monaldi Arch Chest Dis. 1998 Oct;53(5):540-2. Monaldi Arch Chest Dis. 1998. PMID: 9861816 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page